Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.
Rizzo M, Abate N, Chandalia M, Rizvi AA, Giglio RV, Nikolic D, Marino Gammazza A, Barbagallo I, Isenovic ER, Banach M, Montalto G, Li Volti G. Rizzo M, et al. Among authors: montalto g. J Clin Endocrinol Metab. 2015 Feb;100(2):603-6. doi: 10.1210/jc.2014-2291. Epub 2014 Nov 13. J Clin Endocrinol Metab. 2015. PMID: 25393640 Free PMC article. Clinical Trial.
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study.
Rizvi AA, Patti AM, Giglio RV, Nikolic D, Amato A, Al-Busaidi N, Al-Rasadi K, Soresi M, Banach M, Montalto G, Rizzo M. Rizvi AA, et al. Among authors: montalto g. Expert Opin Biol Ther. 2015;15(10):1391-7. doi: 10.1517/14712598.2015.1067299. Epub 2015 Jul 20. Expert Opin Biol Ther. 2015. PMID: 26195184 Clinical Trial.
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.
Nikolic D, Castellino G, Banach M, Toth PP, Ivanova E, Orekhov AN, Montalto G, Rizzo M. Nikolic D, et al. Among authors: montalto g. Curr Pharm Des. 2017 Mar 26;23(6):894-902. doi: 10.2174/1381612822666161006151134. Curr Pharm Des. 2017. PMID: 27719644 Review.
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A. Rizzo M, et al. Among authors: montalto g. Cardiovasc Diabetol. 2016 Dec 3;15(1):162. doi: 10.1186/s12933-016-0480-8. Cardiovasc Diabetol. 2016. PMID: 27912784 Free PMC article. Clinical Trial.
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.
Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M. Patti AM, et al. Among authors: montalto g. Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10. Diabetes Res Clin Pract. 2019. PMID: 30759365
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study.
Castellino G, Nikolic D, Magán-Fernández A, Malfa GA, Chianetta R, Patti AM, Amato A, Montalto G, Toth PP, Banach M, Cicero AFG, Rizzo M. Castellino G, et al. Among authors: montalto g. Nutrients. 2019 Oct 25;11(11):2580. doi: 10.3390/nu11112580. Nutrients. 2019. PMID: 31731527 Free PMC article. Clinical Trial.
Non-glycemic effects of pioglitazone and incretin-based therapies.
Rizzo M, Avogaro A, Montalto G, Rizvi AA. Rizzo M, et al. Among authors: montalto g. Expert Opin Ther Targets. 2013 Jul;17(7):739-42. doi: 10.1517/14728222.2013.804067. Epub 2013 May 22. Expert Opin Ther Targets. 2013. PMID: 23691979
482 results